Lewy Body Dementia Treatment Market Share, Trend Analysis, Key Drivers, Size And Forecast To 2033 | Mallinckrodt Pharmaceuticals Co., BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc., Allergan PLC

Overview and Scope
Lewy body dementia treatment refers to medications and nonmedical therapies, such as physical, occupational, and speech therapies, to manage symptoms as much as possible. The treatment is used for the healing and control of some of the symptoms and to reduce hallucinations, confusion, drowsiness, movement problems, and disturbed sleep.

Sizing and Forecast
The lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%.  The  growth in the historic period can be attributed to supportive care and family education, regulatory approvals and guideline, multidisciplinary care approaches, psychosocial and behavioral interventions, multidisciplinary care approaches..

The lewy body dementia treatment market size is expected to see strong growth in the next few years. It will grow to $5.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.  The growth in the forecast period can be attributed to advancements in neurology, focused research initiatives, precision medicine and biomarkers, collaborative healthcare models, telemedicine expansion.. Major trends in the forecast period include family and caregiver support, integrated care models, personalized treatment approaches, non-pharmacological interventions, digital health solutions..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Segmentation & Regional Insights
The lewy body dementia treatment market covered in this report is segmented –
1) By Drug Type: Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase inhibitors, Modafinil
2) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Alzheimer’s disease, Dementia, Parkinson’s disease

Top 5 major Players:

• Mallinckrodt Pharmaceuticals Co.,
• BioArctic AB,
• Sumitomo Pharma Co. Ltd.,
• Jazz Pharmaceuticals Inc.,
• Allergan PLC

North America was the largest region in the Lewy body dementia treatment market in 2023. The regions covered in the lewy body dementia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9387&type=smp

Major Driver Impacting Market Growth
The rising prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia treatment market going forward. Brain disorders refer to any disorder that impairs brain function. The impairment can be mild, moderate, or severe, depending on the extent of brain damage. Lewy body dementia treatment is used to treat brain disorders such as hallucinations, confusion, and drowsiness by increasing brain chemicals to improve alertness and cognition. For instance, in January 2022, according to a report shared by the American Heart Association Inc., a US-based nonprofit voluntary organization, brain disorders are expected to increase to 9.3 million in the US by 2060, and currently, this number is growing in the US. And one in every six people worldwide suffers from a brain disease. Currently, 1 billion people will suffer from brain disorders worldwide by 2021. Therefore, the rising prevalence of brain-related disorders is driving the growth of the lewy body dementia treatment market.

Key Industry Players
Major companies operating in the lewy body dementia treatment market is focused on providing revolutionary transdermal systems that leverage innovative technology such as CORPLEX technology for Alzheimer’s Dementia Treatment. CORPLEX technology is a proprietary transdermal drug delivery platform that is designed to optimize clinical benefits for patients by enabling continuous, controlled, and sustained release of a drug. For instance, in September 2022, Corium, a US-based biopharmaceutical leader in CNS therapies, introduced ADLARITY, a once-weekly transdermal system delivering donepezil for Alzheimer’s patients, which is part of the disease in Lewy body dementia. It offers consistent dosing and minimizes GI side effects. Corium’s CORPLEX technology enables sustained drug release, enhancing its CNS pipeline. It is available in 5mg or 10mg.

The lewy body dementia treatment market report table of contents includes:
1. Executive Summary
2. Lewy Body Dementia Treatment Market Characteristics
3. Lewy Body Dementia Treatment Market Trends And Strategies
4. Lewy Body Dementia Treatment Market – Macro Economic Scenario
5. Global Lewy Body Dementia Treatment Market Size and Growth

….

31. Global Lewy Body Dementia Treatment Market Competitive Benchmarking
32. Global Lewy Body Dementia Treatment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Lewy Body Dementia Treatment Market
34. Lewy Body Dementia Treatment Market Future Outlook and Potential Analysis
35. Appendix

List of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Lewy Body Dementia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Lewy Body Dementia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Lewy Body Dementia Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

…..

Table 74: Mallinckrodt Pharmaceuticals Co. Financial Performance
Table 75: BioArctic AB Financial Performance
Table 76: Sumitomo Pharma Co. Ltd. Financial Performance
Table 77: Jazz Pharmaceuticals Inc. Financial Performance
Table 78: Allergan plc Financial Performance

Explore the trending research reports from TBRC:
https://topprnews.com/holographic-display-market-size/
https://topprnews.com/intelligent-remote-terminal-unit-market-size/
https://topprnews.com/marine-acoustic-sensors-market-share/
https://goodprnews.com/holographic-display-market-size/
https://goodprnews.com/intelligent-remote-terminal-unit-market-size/
https://goodprnews.com/marine-acoustic-sensors-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model